Terlipressin in catecholamine-resistant hyperdynamic shock patients after cardiac surgery
Ludhmila Abrahão Hajjar(Universidade de São Paulo), José Otávio Costa Auler Júnior(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Márcia Cristina da Silva Magro(Universidade de Brasília), Filomena Regina Barbosa Gomes Galas, T Ticom(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Leticia P. B Sampaio(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo)
Cited by 124
Related Papers
Transfusion Requirements After Cardiac Surgery
|JAMA|2010|1k
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767
Lung Pathology in Fatal Novel Human Influenza A (H1N1) Infection
|American Journal of Respiratory and Critical Care Medicine|2009|551
Goal-directed fluid management based on pulse pressure variation monitoring during high-risk surgery: a pilot randomized controlled trial
|Critical Care|2007|454
Vasopressin versus Norepinephrine in Patients with Vasoplegic Shock after Cardiac Surgery
|Anesthesiology|2016|356